Sugar Editorial Picks
Jul 23, 2007 -
When I walked into my first few yoga classes, I was intrigued by all the blocks neatly stacked against the wall next to the perfectly rolled-up mats. I soon came to realize that those different sized blocks had many useful purposes.
Blocks are often used by beginners and those with injuries to help them modify certain postures, but they are also used by experienced and flexible yogis as tools to get deeper into poses.
- 3 Comments
Other Search Results
Nov 17, 2009 -
Much has been made of late about exercise and its relation to weight loss. There was the Time cover story The Myth About Weight Loss and a recent article on the topic in the New York Times, which recommended working out in the fat burning zone.
You see the phrase on all types of cardio machines: the fat burning zone, aka the "weight loss zone," means working out at a lower intensity to burn fat as fuel.
- 13 Comments
Nov 04, 2009 -
Conservative columnist David Brooks wrote an essay in the New York Times yesterday about how technology is ruining love and sex for the youngins.
Although Brooks reaches this conclusion based on the testimony of some horndogs who agreed to be "online sex diarists" for New York magazine (he admits it's a pretty unrepresentative demographic), Brooks nevertheless believes their stories tell us something fundamental about love in the age of technology: it's allowed people to treat potential sex partners (and it's significantly limited to this) as if they were products on eBay.
Once upon a time — in what we might think of as the "Happy Days era" — courtship was governed by a set of guardrails.
- 6 Comments
Sep 22, 2009 -
In a recent post about which diets match your personality, one diet mentioned was The Volumetrics Eating Plan. Designed by nutritionist Barbara Rolls, PhD, it's based on the simple fact that people love food. It doesn't deprive you of any types of food, since limiting your diet too severely can cause you to binge and won't help you lose weight.
- 4 Comments
Aug 28, 2009 -
To be filed right next to New Delhi's record for the world's largest biryani: Sankalp, a restaurant chain based in the city of Ahmedabad, India, claims to have made the world's longest dosa.
The mammoth dosa — a crepelike South Indian specialty made from rice and black lentils — was created last Wednesday and measured in at 32 feet and 5 inches long, taking less than 40 minutes to put together. To make the behemoth, a team of 16 chefs practiced for 10 days, working to achieve the correct length by maintaining a steady temperature across the entire dosa, while handling a tawa, or hot plate, that was 35 feet long.
- 1 Comment
May 19, 2009 -
According to a new Gallup poll, the Republican party has lost support in nearly every demographic of American society — be it low-income, high-income, college educated, male, female, southern, white, or nonwhite voters. Support remains steady only among frequent churchgoers.
In the general population, Republicans trail Democrats in support by a 14-point margin, compared to an even split in 2001.
- 23 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Symptoms
- Risk Factors
- Causes
- Prognosis
- Diagnosis
- Common Brain Tumors
- Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Other Treatments
- Treatment of Complications...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Radiation Therapy Complications
- Radiation therapy in children with cancer increases the risk of new brain and spinal cord tumors, suggests a study in the Journal of the National Cancer Institute. The risk appears to increase along with the radiation dosage. Children who receive radiotherapy before age 5 are especially at risk for second primary tumors.
- Survivors of childhood brain tumors who received cranial radiotherapy as part of their treatment are at risk for later having a stroke, indicates a study in the Journal of Clinical Oncology.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Diagnosis
- Hepatitis A
- Hepatitis B and D
- Hepatitis C
- Autoimmune Hepatitis
- Symptom Management
- Outlook
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2006, the FDA approved telbivudine (Tyzeka), a new type of nucleoside analog drug, for treatment of chronic hepatitis B. There are now six drugs approved for hepatitis B treatment.
- In 2007, the FDA approved HepaGam B, an intravenous immune globulin drug, for preventing hepatitis B recurrence following liver transplantation.
Drug Warning
In 2007, the FDA revised the prescribing label for entecavir (Baraclude), a drug used to treat hepatitis B. The new label advises against using entacavir in patients infected with both hepatitis B and HIV who are not receiving antiretroviral (anti-HIV) therapy.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Biological and Medical Caus...
- Cultural and Emotional Caus...
- Risk Factors
- Complications
- Weight Loss and Maintenance...
- Weight Management
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Cancer and Weight Control:
- Cancer prevention guidelines from the American Cancer Society stress the importance of maintaining a healthy weight throughout life. A healthy weight is even more important than eating specific healthy foods, when it comes to cancer prevention.
Drug Warning:
- The US Food and Drug Administration (FDA) is warning consumers not to buy a product known as the "Brazilian diet pill." This product is labeled as a dietary supplement, but contains several chemicals found in powerful prescription drugs.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Screening Tests
- Treatment
- Lifestyle Changes
- Medications
- Long-Term Complications
- Emergency Complications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- Sitagliptin (Januvia), the first in a new class of diabetes drugs called DPP-4 inhibitors, was approved in 2006.
- Janumet, a 2-in-1 pill that contains both sitagliptin and metformin, was approved in 2007.
- These drugs are taken by mouth and may be more convenient for patients than exenatide (Byetta), a similar drug. DPP-4 inhibitors do not cause weight gain and may pose a lower risk for hypoglycemia than some other diabetes drugs.
Drug Safety Alert
Rosiglitazone (Avandia) may significantly increase the risk for heart attack, indicates a review published in the Journal of the American Medical Association. In 2007, a panel of experts from the Food and Drug Administration (FDA) agreed the drug increases the risk of heart attacks -- but concluded it should remain on the market.
- 4 Comments